5730455P16Rik activators encompass a diverse array of chemical compounds that facilitate the enhancement of the protein's functional activity through various intracellular signaling pathways. Compounds such as Forskolin and Epigallocatechin gallate elevate the activity of 5730455P16Rik by modulating levels of secondary messengers and kinase activity, respectively. Forskolin's ability to raise cAMP levels indirectly activates protein kinase A, which could phosphorylate 5730455P16Rik, thereby enhancing its activity. Epigallocatechin gallate, known for its kinase inhibitory properties, may reduce competitive or regulatory signaling, allowing for the increased activity of 5730455P16Rik. Similarly, Genistein, by inhibiting tyrosine kinases, and Staurosporine, through broad-spectrum kinase inhibition, may lift the restraints on 5730455P16Rik's activity imposed by these kinases.
5730455P16Rik activators encompass a diverse array of chemical compounds that facilitate the enhancement of the protein's functional activity through various intracellular signaling pathways. Compounds such as Forskolin and Epigallocatechin gallate elevate the activity of 5730455P16Rik by modulating levels of secondary messengers and kinase activity, respectively. Forskolin's ability to raise cAMP levels indirectly activates protein kinase A, which could phosphorylate 5730455P16Rik, thereby enhancing its activity. Epigallocatechin gallate, known for its kinase inhibitory properties, may reduce competitive or regulatory signaling, allowing for the increased activity of 5730455P16Rik. Similarly, Genistein, by inhibiting tyrosine kinases, and Staurosporine, through broad-spectrum kinase inhibition, may lift the restraints on 5730455P16Rik's activity imposed by these kinases. Compounds like PMA and Sphingosine-1-phosphate act on protein kinase C and sphingosine-1-phosphate receptors, respectively, which could lead to the phosphorylation and functional activation of 5730455P16Rik if it is part of their signaling cascades.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate engages with its receptors to regulate cellular signaling pathways including those that might control the localization and function of 5730455P16Rik, consequently enhancing its activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This compound is a kinase inhibitor that may reduce competitive signaling pathways, thereby freeing up 5730455P16Rik to be more active within its specific signaling axis. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which may phosphorylate and enhance the activity of 5730455P16Rik if it is a PKC substrate. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that modulates the PI3K/AKT pathway, potentially allowing for the relief of inhibitory control over 5730455P16Rik, thereby enhancing its activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is also a PI3K inhibitor that can enhance the activity of 5730455P16Rik by reducing PI3K/AKT pathway activity, which might otherwise sequester factors that activate 5730455P16Rik. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
By increasing intracellular calcium levels, thapsigargin can activate calcium-dependent signaling pathways that may enhance the activity of 5730455P16Rik. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium concentration, potentially enhancing the activity of 5730455P16Rik through calcium signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor which could shift signaling dynamics in favor of pathways that activate 5730455P16Rik by inhibiting the MEK/ERK pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This compound is a p38 MAPK inhibitor, potentially enhancing the activity of 5730455P16Rik by altering the signaling landscape to support pathways in which 5730455P16Rik is involved. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that may relieve 5730455P16Rik from competitive or regulatory tyrosine kinase phosphorylation, thereby enhancing its activity. | ||||||